Literature DB >> 26422859

Determination-of apoptosis and cell cycle modulators (p16, p21, p27, p53, BCL-2, Bax, BCL-xL, and cyclin D1) in thyroid follicular carcinoma, follicular adenoma, and adenomatous nodules via a tissue microarray method.

Peyker Temiz, Gizem Akkaş, Nalan Neşe, Fazilet Uğur Duman, Cansu Karakaş, Yamaç Erhan.   

Abstract

BACKGROUND/AIM: To identify the role of gene products associated with apoptosis and cell cycle in the pathogenesis of thyroid follicular neoplasm.
MATERIALS AND METHODS: Thirty follicular adenomas (FAs), 16 follicular carcinomas (FCs), and 20 adenomatous nodules (ANs) were investigated with immunohistochemical staining of p16, p21, p27, p53, Bcl-2, Bax, Bcl-xL, and cyclin D1 via a tissue microarray method.
RESULTS: Bcl-2 showed a significant difference between the benign groups (AN and FA) and the malignant group (FC). Bax was significantly higher in the FC group. p53 was lowest in the AN group and highest in the FC group with significant differences between the groups. p16 was significantly higher in the FC group than in the other groups. There was a significant difference between the AN group and neoplastic lesions in terms of p21 staining. The number of cases with positive p27 was lower in the AN group than the neoplastic groups. There was no significant difference in terms of Bcl-xL and cyclin D1.
CONCLUSION: Cell cycle modulators, led by the Bcl-2 family, played an important role in the pathogenesis of thyroid follicular neoplasm, and p53, p16, and p21 in particular played a role in the carcinogenesis of FC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26422859     DOI: 10.3906/sag-1406-48

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  5 in total

1.  Association of Pro-apoptotic Bad Gene Expression Changes with Benign Thyroid Nodules.

Authors:  Nurdan Gül; Berna Temel; Duran Ustek; Sema Sirma-Ekmekçi; Yersu Kapran; Fatih Tunca; Yasemin Giles-Şenyürek; Uğur Özbek; Faruk Alagöl
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

2.  Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

Authors:  Zhenyu Hou; Yunfeng Cui; Huizhi Xing; Xiaoyan Mu
Journal:  Oncol Lett       Date:  2017-11-29       Impact factor: 2.967

3.  TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.

Authors:  Li Liu; Xiao-Ming Zhou; Fang-Fei Yang; Yuan Miao; Yan Yin; Xue-Jun Hu; Gang Hou; Qiu-Yue Wang; Jian Kang
Journal:  Oncotarget       Date:  2017-07-01

4.  Effects of ANCR lncRNA on the biological behaviors of lung cancer cells A549 and the mechanism.

Authors:  Chengyao Ni; Peng Teng; Peng Hu
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

5.  c[RGDyk]-coated liposomes loaded with adriamycin and miR-21 mimics inhibit the growth of hepatoma cell line SMCC-7721 via up-regulating Bax and p53.

Authors:  Xiaoyong Wei; Xiaolong You; Jianlong Zhang; Cuncai Zhou
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.